# 510(k) SUBSTANTIAL EQUIVALENCE DETERMINATION DECISION SUMMARY ASSAY ONLY TEMPLATE

A. 510(k) Number: k160793   
B. Purpose for Submission: New Device   
C. Measurand: MDMA (Methylenedioxymethaneamphetamine) EDDP (2-ethylidene-1,5-dimethyl-3,3- diphenylpyrrolidine) Nortriptyline   
D. Type of Test: Qualitative Assay   
E. Applicant: W. H. P. M., Inc.

# F. Proprietary and Established Names:

First Sign Drug of Abuse MDMA Cup Test First Sign Drug of Abuse MDMA Dip Card Test First Sign Drug of Abuse EDDP Cup Test First Sign Drug of Abuse EDDP Dip Card Test First Sign Drug of Abuse Nortriptyline Cup Test First Sign Drug of Abuse Nortriptyline Dip Card Test

G. Regulatory Information:   

<table><tr><td rowspan=1 colspan=1>Product Code</td><td rowspan=1 colspan=1>Classification</td><td rowspan=1 colspan=1>RegulationSection</td><td rowspan=1 colspan=1>Panel</td></tr><tr><td rowspan=1 colspan=1>LAF</td><td rowspan=1 colspan=1>Class II</td><td rowspan=1 colspan=1>862.3610</td><td rowspan=1 colspan=1>91-Toxicology</td></tr><tr><td rowspan=1 colspan=1>DJR</td><td rowspan=1 colspan=1>Class II</td><td rowspan=1 colspan=1>862.3620</td><td rowspan=1 colspan=1>91-Toxicology</td></tr><tr><td rowspan=1 colspan=1>LFG</td><td rowspan=1 colspan=1>Class II</td><td rowspan=1 colspan=1>862.3910</td><td rowspan=1 colspan=1>91-Toxicology</td></tr></table>

# H. Intended Use:

1. Intended use(s): See indications for Use below.

2. Indication(s) for use:

First Sign Drug of Abuse MDMA Cup Test   
First Sign Drug of Abuse MDMA Dip Card Test   
First Sign Drug of Abuse MDMA Tests are immunoassay tests. The test can detect MDMA in human urine. The cut-off value is $5 0 0 ~ \mathrm { { n g / m L } }$ . The tests are available in a Cup format and a Dip Card format.

The tests provide only preliminary test results. If you want to get a confirmed result, you must use a more specific chemical method. Gas Chromatography/Mass Spectrometry is the preferred confirmatory method. Clinical consideration and professional judgment should be used when you get any drug of abuse test result. It should be used particularly when the preliminary result is positive.

For in vitro diagnostic use only. The tests are intended for over-the-counter and for prescription use.

First Sign Drug of Abuse EDDP Cup Test   
First Sign Drug of Abuse EDDP Dip Card Test   
First Sign Drug of Abuse EDDP Tests are immunoassay tests. The test can detect EDDP in human urine. The cut-off value is $3 0 0 ~ \mathrm { { n g / m L } }$ . The tests are available in a Cup format and a Dip Card format.

The tests provide only preliminary test results. If you want to get a confirmed result, you must use a more specific chemical method. Gas Chromatography/Mass Spectrometry is the preferred confirmatory method. Clinical consideration and professional judgment should be used when you get any drug of abuse test result. It should be used particularly when the preliminary result is positive.

For in vitro diagnostic use only. The tests are intended for over-the-counter and for prescription use.

First Sign Drug of Abuse Nortriptyline Cup Test   
First Sign Drug of Abuse Nortriptyline Dip Card Test   
First Sign Drug of Abuse Nortriptyline Tests are immunoassay tests. The test can detect Nortriptyline in human urine. The cut-off value is $1 { , } 0 0 0 \mathrm { n g / m L }$ . The tests are available in a Cup format and a Dip Card format.

The tests provide only preliminary test results. If you want to get a confirmed result, you must use a more specific chemical method. Gas Chromatography/Mass Spectrometry is the preferred confirmatory method. Clinical consideration and professional judgment should be used when you get any drug of abuse test result. It should be used particularly

when the preliminary result is positive.   
For in vitro diagnostic use only. The tests are intended for over-the-counter and for prescription use.

3. Special conditions for use statement(s): For over-the-counter and prescription use

4. Special instrument requirements: Not applicable. The devices are visually read and single-use.

# I. Device Description:

These devices are immunochromatographic assays for MDMA, EDDP and Nortriptyline Urine Tests use a lateral flow, one step system for the qualitative detection of MDMA, EDDP and Nortriptyline in human urine. Each assay uses a monoclonal antibody-dye conjugate against drugs with gold chloride and fixed drug-protein conjugates and antimouse IgG polyclonal antibody in membranes.

The assays in this submission include a dip card and cup formats. Each assay and format is available separately.

# J. Substantial Equivalence Information:

1. Predicate device name(s): Co-Innovation Biotech One Step Single/Multi-Drug Test

2. Predicate 510(k) number(s): k142800 k140748

3. Comparison with predicate:

<table><tr><td colspan="3" rowspan="1">Similarities</td></tr><tr><td colspan="1" rowspan="1">Item</td><td colspan="1" rowspan="1">Candidate Device</td><td colspan="1" rowspan="1">Predicate (k142800)</td></tr><tr><td colspan="1" rowspan="1">Intended Use</td><td colspan="1" rowspan="1">For the qualitativedetermination ofMDMA in human urine.</td><td colspan="1" rowspan="1">Rapid Single/Multi-drug test Cupand Rapid Single/Multi-drug testDipcard are lateral flowchromatographic immunoassaysdesigned to qualitatively detect thepresence of drugs and drugmetabolites in human urine</td></tr><tr><td colspan="1" rowspan="1">Calibrator Drug</td><td colspan="1" rowspan="1">MDMA</td><td colspan="1" rowspan="1">Delta-9-THC-COOHBenzolecgonine</td></tr><tr><td colspan="1" rowspan="1">−</td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">D-AmphetamineD-MethamphetamineMorphineSecobarbitalOxazepam3,4-MethylenedioxymethamphetamineMethadoneOxycodonePhencyclidine</td></tr><tr><td colspan="1" rowspan="1">Methodology</td><td colspan="1" rowspan="1">Competitive binding,lateral flowimmunochromatographicassays basedon the principle of antigenantibodyimmunochemistry.</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">Specimen Type</td><td colspan="1" rowspan="1">Human Urine</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">Cut-Off Values</td><td colspan="1" rowspan="1">500 ng/mL (MDMA)</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">IntendedPopulations</td><td colspan="1" rowspan="1">For over-the-counter useand prescription uses</td><td colspan="1" rowspan="1">Same</td></tr></table>

<table><tr><td colspan="3" rowspan="1">Similarities</td></tr><tr><td colspan="1" rowspan="1">Item</td><td colspan="1" rowspan="1">Candidate Device</td><td colspan="1" rowspan="1">Predicate (k140748)</td></tr><tr><td colspan="1" rowspan="1">Intended Use</td><td colspan="1" rowspan="1">For the qualitativedetermination ofEDDP and Nortriptyline inhuman urine.</td><td colspan="1" rowspan="1">One Step Single/Multi-drug TestCup and One Step Single/Multi-drug Test Dipcard are lateral flowchromatographic immunoassaysdesigned to qualitatively detect thepresence of drugs and drugmetabolites in human urine</td></tr><tr><td colspan="1" rowspan="1">Calibrator Drug</td><td colspan="1" rowspan="1">EDDPNortriptyline</td><td colspan="1" rowspan="1">Buprenorphine2-ethylidene-1, 5-dimethyl-3,3-diphenylpyrrolidine"MorphinePropoxypheneNortriptyline</td></tr><tr><td colspan="1" rowspan="1">Methodology</td><td colspan="1" rowspan="1">Competitive binding,lateral flowimmunochromatographicassays basedon the principle of antigenantibody</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">immunochemistry.</td><td colspan="1" rowspan="1"></td></tr><tr><td colspan="1" rowspan="1">Specimen Type</td><td colspan="1" rowspan="1">HumanUrine</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">Cut-Off Values</td><td colspan="1" rowspan="1">300 ng/mL (EDDP)1000 ng/mL(Nortriptyline)</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">IntendedPopulations</td><td colspan="1" rowspan="1">For over-the-counter useand prescription uses</td><td colspan="1" rowspan="1">Same</td></tr></table>

# K. Standard/Guidance Document Referenced (if applicable):

None were referenced

# L. Test Principle:

First Sign Drug of Abuse MDMA Test, First Sign Drug of Abuse EDDP Test and First Sign Drug of Abuse Nortriptyline Test are immunochromatographic assays. Each assay test is a lateral flow system for the qualitative detection of MDMA, or EDDP or Nortriptyline in human urine. During testing, a urine specimen migrates upward by capillary action. If target drugs are present in the urine specimen below its cut-off concentration, it will not saturate the binding sites of its specific antibody (monoclonal mouse antibody) coated on the particles. The antibody-coated particles will then be captured by immobilized drug-conjugate and a visible colored line will show up in the test line region. The colored line will not form in the test line region if the target drug level exceeds its cut-off concentration because it will saturate all the binding sites of the antibody coated on the particles. A band should form in the control region of the devices regardless of the presence of drug or metabolite in the sample.

# M. Performance Characteristics (if/when applicable):

1. Analytical performance:

# a. Precision/Reproducibility:

Precision studies were carried out for samples with concentrations of - $- 1 0 0 \%$ cut-off, - $7 5 \%$ cut-off, $- 5 0 \%$ cut-off, $- 2 5 \%$ cut-off, at the cut-off, $+ 2 5 \%$ cut-off, $+ 5 0 \%$ cut-off, $+ 7 5 \%$ cut-off and $+ 1 0 0 \%$ cut-off. These samples were prepared by spiking drug in negative urine samples. Each drug concentration was confirmed by GC/MS. All sample aliquots were blinded labeled and randomized. For each concentration, tests were performed two runs per day for 25 days.

# MDMA Dip Card

<table><tr><td rowspan=1 colspan=1>MDMA</td><td rowspan=1 colspan=1>-100%cut off</td><td rowspan=1 colspan=1>-75%cut off</td><td rowspan=1 colspan=1>-50%cut off</td><td rowspan=1 colspan=1>-25%Cutoff</td><td rowspan=1 colspan=1>cut off</td><td rowspan=1 colspan=1>+25%cutoff</td><td rowspan=1 colspan=1>+50%cutoff</td><td rowspan=1 colspan=1>+75%cutoff</td><td rowspan=1 colspan=1>+100%cutoff</td></tr><tr><td rowspan=1 colspan=1>Lot 1</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>2-/48+</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr><tr><td rowspan=1 colspan=1>Lot 2</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>3-/47+</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr><tr><td rowspan=1 colspan=1>Lot 3</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>3-/47+</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr></table>

MDMA Cup   

<table><tr><td>MDMA</td><td>-100% cut off</td><td>-75% cut off</td><td>-50% cut off</td><td>-25% Cutof f</td><td>cut off</td><td>+25% cutoff</td><td>+50% cutoff</td><td>+75% cutoff</td><td>+100% cut off</td></tr><tr><td>Lot 4</td><td>50-/0+</td><td>50-/0+</td><td>50-/0+</td><td>50-/0+</td><td>3-/47+</td><td>50+/0-</td><td>50+/0-</td><td>50+/0-</td><td>50+/0-</td></tr><tr><td>Lot 5</td><td>50-/0+</td><td>50-/0+</td><td>50-/0+</td><td>50-/0+</td><td>2-/48+</td><td>50+/0-</td><td>50+/0-</td><td>50+/0-</td><td>50+/0-</td></tr><tr><td>Lot 6</td><td>50-/0+</td><td>50-/0+</td><td>50-/0+</td><td>50-/0+</td><td>2-/48+</td><td>50+/0-</td><td>50+/0-</td><td>50+/0-</td><td>50+/0-</td></tr></table>

EDDP Dip Card   

<table><tr><td rowspan=1 colspan=1>EDDP</td><td rowspan=1 colspan=1>-100%cut off</td><td rowspan=1 colspan=1>-75%cut off</td><td rowspan=1 colspan=1>-50%cut off</td><td rowspan=1 colspan=1>-25%Cutoff</td><td rowspan=1 colspan=1>cut off</td><td rowspan=1 colspan=1>+25%cutoff</td><td rowspan=1 colspan=1>+50%cutoff</td><td rowspan=1 colspan=1>+75%cutoff</td><td rowspan=1 colspan=1>+100%cut off</td></tr><tr><td rowspan=1 colspan=1>Lot 1</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>3-/47+</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr><tr><td rowspan=1 colspan=1>Lot 2</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>2-/48+</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr><tr><td rowspan=1 colspan=1>Lot 3</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>2-/48+</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr></table>

EDDP Cup   

<table><tr><td rowspan=1 colspan=1>EDDP</td><td rowspan=1 colspan=1>-100%cut off</td><td rowspan=1 colspan=1>-75%cut off</td><td rowspan=1 colspan=1>-50%cut off</td><td rowspan=1 colspan=1>-25%Cutoff</td><td rowspan=1 colspan=1>cut off</td><td rowspan=1 colspan=1>+25%cutoff</td><td rowspan=1 colspan=1>+50%cutoff</td><td rowspan=1 colspan=1>+75%cutoff</td><td rowspan=1 colspan=1>+100%cut off</td></tr><tr><td rowspan=1 colspan=1>Lot 4</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>2-/48+</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr><tr><td rowspan=1 colspan=1>Lot 5</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>2-/48+</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr><tr><td rowspan=1 colspan=1>Lot 6</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>3-/47+</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr></table>

Nortriptyline Dip Card   

<table><tr><td rowspan=1 colspan=1>Nortriptyline</td><td rowspan=1 colspan=1>-100%cut off</td><td rowspan=1 colspan=1>-75%cut off</td><td rowspan=1 colspan=1>-50%cut off</td><td rowspan=1 colspan=1>-25%Cutoff</td><td rowspan=1 colspan=1>cut off</td><td rowspan=1 colspan=1>+25%cutoff</td><td rowspan=1 colspan=1>+50%cutoff</td><td rowspan=1 colspan=1>+75%cutoff</td><td rowspan=1 colspan=1>+100%cut off</td></tr><tr><td rowspan=1 colspan=1>Lot 1</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>3-/47+</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr><tr><td rowspan=1 colspan=1>Lot 2</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>2-/48+</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr><tr><td rowspan=1 colspan=1>Lot 3</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>2-/48+</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr></table>

Nortriptyline Cup   

<table><tr><td>Nortriptyline</td><td>100% cut off</td><td>-75% cut off</td><td>-50% cut off</td><td>-25% Cutoff</td><td>cut off</td><td>+25% cutoff</td><td>+50% cutoff</td><td>+75% cutoff</td><td>+100% cut off</td></tr><tr><td>Lot 4</td><td>50-/0+</td><td>50-/0+</td><td>50-/0+</td><td>50-/0+</td><td>2-/48+</td><td>50+/0-</td><td>50+/0-</td><td>50+/0-</td><td>50+/0-</td></tr><tr><td>Lot 5</td><td>50-/0+</td><td>50-/0+</td><td>50-/0+</td><td>50-/0+</td><td>3-/47+</td><td>50+/0-</td><td>50+/0-</td><td>50+/0-</td><td>50+/0-</td></tr><tr><td>Lot 6</td><td>50-/0+</td><td>50-/0+</td><td>50-/0+</td><td>50-/0+</td><td>3-/47+</td><td>50+/0-</td><td>50+/0-</td><td>50+/0-</td><td>50+/0-</td></tr></table>

b. Linearity/assay reportable range:

Not applicable, these devices are intended for qualitative use only.

c. Traceability, Stability, Expected values (controls, calibrators, or methods):

# Stability

Real-time and accelerated stability studies were conducted on three lots of each device. The protocols for the stability studies were reviewed and found to be acceptable. The results of these studies indicated that all devices were found to be stable at $4 { - } 3 0 ^ { \circ } \mathrm { C }$ $( 3 9 { - } 8 6 ^ { \circ } \mathrm { F } )$ for 24 months based on the accelerated stability study at $5 0 \%$ and a shelf life study at $3 0 \%$ . Control materials are not provided with the device. The labeling provides information on how to obtain control materials.

# Transportation Study

A Transportation stability study was conducted on three lots of each device. The protocols for the transportation stability study were reviewed and found to be acceptable. The results of these studies indicated that all devices were found to be stable during transport of the device in temperatures between $- 2 0$ and $4 0 \%$ .

d. Detection limit:

Not applicable.

e. Analytical specificity:

Compounds sharing structural or conformational similarity with the analytes were tested for cross-reactivity with the candidate device. The structurally related compounds that exhibited cross-reactivity with the candidate device were titrated to determine the percent cross-reactivity. The concentration $( \mathrm { n g / m L } )$ of cross-reactant that gives a response equivalent to the cutoff, and the percent cross-reactivity are presented in the table below.

MDMA Cross Reactivity   

<table><tr><td colspan="1" rowspan="1">Drugs</td><td colspan="1" rowspan="1">Concentration(ng/ml)</td><td colspan="1" rowspan="1">Reactivity</td></tr><tr><td colspan="1" rowspan="1">Methylenedioxymethamphetamine(MDMA)</td><td colspan="1" rowspan="1">500</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="1">3,4-Methylenedioxyamphetamine(MDA)</td><td colspan="1" rowspan="1">8000</td><td colspan="1" rowspan="1">6.3%</td></tr><tr><td colspan="1" rowspan="1">3,4-Methylenedioxyethylamphetamine(MDEA)</td><td colspan="1" rowspan="1">1000</td><td colspan="1" rowspan="1">50%</td></tr><tr><td colspan="1" rowspan="1">Ephedrine</td><td colspan="1" rowspan="1">40000</td><td colspan="1" rowspan="1">1.3%</td></tr><tr><td colspan="1" rowspan="1">d-methamphetamine</td><td colspan="1" rowspan="1">Negative at</td><td colspan="1" rowspan="1">Not Detected</td></tr><tr><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">100000</td><td colspan="1" rowspan="1"></td></tr><tr><td colspan="1" rowspan="1">d-amphetamine</td><td colspan="1" rowspan="1">Negative at100000</td><td colspan="1" rowspan="1">Not Detected</td></tr><tr><td colspan="1" rowspan="1">1-amphetamine</td><td colspan="1" rowspan="1">Negative at100000</td><td colspan="1" rowspan="1">Not Detected</td></tr><tr><td colspan="1" rowspan="1">1-methamphetamine</td><td colspan="1" rowspan="1">Negative at100000</td><td colspan="1" rowspan="1">Not Detected</td></tr></table>

EDDP Cross Reactivity   

<table><tr><td rowspan=1 colspan=1>Drugs</td><td rowspan=1 colspan=1>Concentration(ng/ml)</td><td rowspan=1 colspan=1>Reactivity</td></tr><tr><td rowspan=1 colspan=1>EDDP (2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine)</td><td rowspan=1 colspan=1>300</td><td rowspan=1 colspan=1>100%</td></tr><tr><td rowspan=1 colspan=1>EMDP (2-Ethyl-5-methyl-3,3-diphenylpyrroline)</td><td rowspan=1 colspan=1>Negative at100000</td><td rowspan=1 colspan=1>NotDetected</td></tr><tr><td rowspan=1 colspan=1>Disopyramide</td><td rowspan=1 colspan=1>Negative at100000</td><td rowspan=1 colspan=1>NotDetected</td></tr><tr><td rowspan=1 colspan=1>Methadone</td><td rowspan=1 colspan=1>Negative at100000</td><td rowspan=1 colspan=1>NotDetected</td></tr><tr><td rowspan=1 colspan=1>LAAM (Levo-alpha-acetylmethadol)</td><td rowspan=1 colspan=1>Negative at100000</td><td rowspan=1 colspan=1>NotDetected</td></tr><tr><td rowspan=1 colspan=1>Alpha Methadol</td><td rowspan=1 colspan=1>Negative at100000</td><td rowspan=1 colspan=1>NotDetected</td></tr><tr><td rowspan=1 colspan=1>Doxylamine</td><td rowspan=1 colspan=1>Negative at100000</td><td rowspan=1 colspan=1>NotDetected</td></tr></table>

Nortriptyline Cross Reactivity   

<table><tr><td colspan="1" rowspan="1">Drugs</td><td colspan="1" rowspan="1">Concentration(ng/ml)</td><td colspan="1" rowspan="1">Reactivity</td></tr><tr><td colspan="1" rowspan="1">Nortriptyline</td><td colspan="1" rowspan="1">1000</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="1">Amitriptyline</td><td colspan="1" rowspan="1">1500</td><td colspan="1" rowspan="1">67%</td></tr><tr><td colspan="1" rowspan="1">Clomipramine</td><td colspan="1" rowspan="1">15000</td><td colspan="1" rowspan="1">6.7%</td></tr><tr><td colspan="1" rowspan="1">Desipramine</td><td colspan="1" rowspan="1">1000</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="1">Doxepine</td><td colspan="1" rowspan="1">2000</td><td colspan="1" rowspan="1">50%</td></tr><tr><td colspan="1" rowspan="1">Imipramine</td><td colspan="1" rowspan="1">600</td><td colspan="1" rowspan="1">167%</td></tr><tr><td colspan="1" rowspan="1">Nordoxepin</td><td colspan="1" rowspan="1">1000</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="1">Promazine</td><td colspan="1" rowspan="1">24000</td><td colspan="1" rowspan="1">4%</td></tr><tr><td colspan="1" rowspan="1">Trimipramine</td><td colspan="1" rowspan="1">4000</td><td colspan="1" rowspan="1">25%</td></tr><tr><td colspan="1" rowspan="1">Cyclobenzaprine</td><td colspan="1" rowspan="1">1500</td><td colspan="1" rowspan="1">67%</td></tr><tr><td colspan="1" rowspan="1">Maprotiline</td><td colspan="1" rowspan="1">Negative at100000</td><td colspan="1" rowspan="1">NotDetected</td></tr><tr><td colspan="1" rowspan="1">Promethazine</td><td colspan="1" rowspan="1">Negative at100000</td><td colspan="1" rowspan="1">NotDetected</td></tr><tr><td colspan="1" rowspan="1">Norclomipramine</td><td colspan="1" rowspan="1">Negative at100000</td><td colspan="1" rowspan="1">NotDetected</td></tr></table>

# Interference Study

Potential interfering substances found in human urine of physiological or pathological conditions were added to drug-free urine and target drugs. These urine samples were tested using three batches of each device for all formats.

Compounds that showed no interference at a concentration of $1 0 0 \mu \mathrm { g / m L }$ for different formats (cup, dipcard) are listed below:

# MDMA Interference

<table><tr><td>4-Acetamidophenol Acetophenetidin</td><td>(L) - Epinephrine Erythromycin</td><td>Pentobarbital Perphenazine</td></tr><tr><td>N-</td><td>β-Estradiol</td><td>Phencyclidine</td></tr><tr><td>Acetylprocainamide</td><td>Estrone-3-sulfate</td><td>Phenelzine</td></tr><tr><td>Acetylsalicylic acid Aminopyrine</td><td>Ethyl-p-aminobenzoate</td><td>Phenobarbital</td></tr><tr><td></td><td>Fenoprofen</td><td>Phentermine</td></tr><tr><td>Amitryptyline</td><td>Furosemide</td><td>Trans-2-</td></tr><tr><td>Amobarbital</td><td>Gentisic acid</td><td>phenylcyclopropylamine</td></tr><tr><td>Amoxicillin</td><td>Hemoglobin</td><td>hydrochloride</td></tr><tr><td>Ampicillin</td><td>Hydralazine</td><td>L-Phenylephrine</td></tr><tr><td>L-Ascorbic acid</td><td>Hydrochlorothiazide</td><td>β-Phenylethylamine</td></tr><tr><td>Apomorphine</td><td>Hydrocodone</td><td>Phenylpropanolamine</td></tr><tr><td>Aspartame</td><td>Hydrocortisone</td><td>Prednisolone</td></tr><tr><td>Atropine</td><td>O-Hydroxyhippuric acid</td><td>Prednisone</td></tr><tr><td>Benzilic acid</td><td>3-Hydroxytyramine</td><td>Procaine</td></tr><tr><td>Benzoic acid</td><td>Ibuprofen</td><td>Promazine</td></tr><tr><td>Benzoylecgonine</td><td>Imipramine</td><td>Promethazine</td></tr><tr><td>Bilirubin</td><td>Iproniazid</td><td>DL-Propranolol</td></tr><tr><td>(±) -</td><td>(±) - Isoproterenol</td><td>D-Propoxyphene</td></tr><tr><td>Brompheniramine</td><td>Isoxsuprine</td><td>D-Pseudoephedrine</td></tr><tr><td>Buspiron</td><td>Ketamine</td><td></td></tr><tr><td>Caffeine</td><td>Ketoprofen</td><td>Quinacrine</td></tr><tr><td>Cannabidiol</td><td>Labetalol</td><td>Quinidine</td></tr><tr><td>Cannabinol</td><td></td><td>Quinine</td></tr><tr><td>Chloralhydrate</td><td>Levorphanol</td><td>Ranitidine</td></tr><tr><td>Chloramphenicol</td><td>Loperamide Maprotiline</td><td>Salicylic acid Secobarbital</td></tr><tr><td>Chlordiazepoxide</td><td>Meperidine Meprobamate</td><td>Serotonin (5- Hydroxytyramine)</td></tr><tr><td>Chlorothiazide (±) -</td><td>Methadone</td><td>Sulfamethazine</td></tr><tr><td>Chlorpheniramine</td><td></td><td></td></tr><tr><td>Chlorpromazine</td><td>Morphine-3-β- Dglucuronide</td><td>Sulindac Sustiva</td></tr><tr><td>Chloroquine</td><td>Morphine sulfate</td><td>Temazepam</td></tr><tr><td>Cholesterol</td><td>Nalidixic acid</td><td>Tetracycline</td></tr><tr><td>Clomipramine</td><td>Naloxone</td><td>Tetrahydrocortisone 3-(β-</td></tr><tr><td>Clonidine</td><td>Naltrexone</td><td>Dglucuronide</td></tr><tr><td>Cocaethylene</td><td>Naproxen</td><td>Tetrahydrozoline</td></tr><tr><td>Cocaine</td><td>Niacinamide</td><td>Thebaine</td></tr><tr><td>hydrochloride</td><td>Nifedipine</td><td>Theophynine</td></tr><tr><td>Codeine</td><td>Nimesulidate</td><td>Thiamine</td></tr><tr><td>Cortisone</td><td>Norcodein</td><td>Thioridazine</td></tr><tr><td>(-) Cotinine</td><td>Norethindrone</td><td>Tolbutamide</td></tr><tr><td>Creatinine</td><td>D-Norpropoxyphene</td><td>Trazodone</td></tr><tr><td>Deoxycorticosterone</td><td>Noscapine</td><td>Triamterene</td></tr><tr><td>Dextromethorphan</td><td>D,L-Octopamine</td><td>DL-Tyrosine</td></tr><tr><td>Diclofenac</td><td>Oxalic acid</td><td></td></tr><tr><td>Diazepam</td><td>Oxazepam</td><td>Trifluoperazine</td></tr><tr><td>Diflunisal</td><td>Oxolinic acid</td><td>Trimethoprim</td></tr><tr><td>Digoxin</td><td></td><td>Trimipramine</td></tr><tr><td>Dicylomine</td><td>Oxycodone</td><td>Tryptamine</td></tr><tr><td></td><td>Oxymetazoline</td><td>D L-Tryptophan</td></tr><tr><td>Diphenhydramine 5,5-</td><td>Papaverine</td><td>Tyramine</td></tr><tr><td>Diphenylhydantoin</td><td>Penicillin-G Pentazocinehydrochloride</td><td>Uric acid</td></tr><tr><td>Doxylamine</td><td></td><td>Verapamil</td></tr><tr><td></td><td></td><td>Zomepirac</td></tr><tr><td>Ecgonine</td><td></td><td></td></tr><tr><td>hydrochloride</td><td></td><td></td></tr><tr><td>Ecgonine</td><td></td><td></td></tr><tr><td>methylester</td><td></td><td></td></tr><tr><td></td><td></td><td></td></tr><tr><td>[1R,2S](-) Ephedrine</td><td></td><td></td></tr></table>

EDDP Interference   

<table><tr><td>Acetaminophen Acetophenetidin Acetylsalicylic acid Amobarbital Aminopyrine Amitryptyline Amoxicillin DL-Amphetamine sulfate Ampicillin Apomorphine</td><td>Ecgonine hydrochloride Ecgonine methylester (IR,2S)(-)Ephedrine Erythromycin β-Estradiol Estrone-3-sulfate Ethyl-p-aminobenzoate Fenoprofen Furosemide</td><td>O-Hydroxyhippuric acid Oxalic acid Oxazepam Oxolinic acid Oxycodone Oxymetazoline Papaverine Penicillin-G</td></tr></table>

<table><tr><td rowspan=1 colspan=4>AspartameAtropineBenzilic acid</td><td rowspan=2 colspan=2>HydrochlorothiazideHydrocodoneHydrocortisonep-Hydroxyamphetamine</td><td></td><td></td></tr><tr><td rowspan=7 colspan=4>Benzoic acidBenzoylecgonineBilirubinBrompheniramineCaffeineCannabidiolCannabinol</td><td></td><td></td></tr><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=2>p-</td><td></td><td></td></tr><tr><td rowspan=1 colspan=2>Hydroxymethamphetamine</td><td></td><td></td></tr><tr><td rowspan=2 colspan=2>3-HydroxytyramineIbuprofen</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td></tr><tr><td></td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=1 colspan=2>Imipramine</td><td></td><td></td></tr><tr><td rowspan=1 colspan=2>(-) Isoproterenol</td><td></td><td></td></tr><tr><td rowspan=1 colspan=4>Chloralhydrate</td><td rowspan=1 colspan=2>Isoxsuprine</td><td></td><td></td></tr><tr><td rowspan=1 colspan=4>Chloramphenicol</td><td rowspan=1 colspan=2>Ketamine</td><td></td><td></td></tr><tr><td rowspan=3 colspan=4>Chlorothiazide(±) -Chlorpheniramine</td><td rowspan=1 colspan=2>Ketoprofen</td><td></td><td></td></tr><tr><td rowspan=1 colspan=2>Labetalol</td><td></td><td></td></tr><tr><td rowspan=1 colspan=2>Levorphanol</td><td></td><td></td></tr><tr><td rowspan=1 colspan=4>Chlorpromazine</td><td rowspan=1 colspan=2>Loperamide</td><td></td><td></td></tr><tr><td rowspan=1 colspan=4>Chloroquine</td><td rowspan=1 colspan=2>L-Phenylephrine</td><td></td><td></td></tr><tr><td rowspan=1 colspan=4>Cholesterol</td><td rowspan=1 colspan=2>Maprotiline</td><td></td><td></td></tr><tr><td rowspan=1 colspan=4>Clomipramine</td><td rowspan=1 colspan=2>Meperidine</td><td></td><td></td></tr><tr><td rowspan=2 colspan=4>ClonidineCocaine</td><td rowspan=1 colspan=2>Meprobamate</td><td rowspan=1 colspan=2>Tetracycline</td></tr><tr><td rowspan=1 colspan=2>Methamphetamine</td><td></td><td></td></tr><tr><td rowspan=1 colspan=4>hydrochloride</td><td rowspan=1 colspan=2>Methoxyphenamine</td><td></td><td></td></tr><tr><td rowspan=1 colspan=4>Codeine</td><td rowspan=1 colspan=2>(±) - 3,4-Methylenedioxy-</td><td></td><td></td></tr><tr><td rowspan=2 colspan=4>(-) CotinineCortisone</td><td rowspan=1 colspan=2>amphetamine</td><td></td><td></td></tr><tr><td rowspan=1 colspan=2>hydrochloride</td><td rowspan=1 colspan=2>Thiamine</td></tr><tr><td rowspan=1 colspan=4>Creatinine</td><td rowspan=1 colspan=2>(±)-3,4-Methylenedioxy-</td><td></td><td></td></tr><tr><td rowspan=1 colspan=4>Deoxycorticosterone</td><td rowspan=1 colspan=2>methamphetamine</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=1 colspan=4>Dextromethorphan</td><td rowspan=1 colspan=2>hydrochloride</td><td></td><td></td></tr><tr><td rowspan=1 colspan=4>Diazepam</td><td rowspan=1 colspan=2>Morphine Sulfate</td><td></td><td></td></tr><tr><td rowspan=4 colspan=4>DiclofenacDiflunisalDigoxin</td><td rowspan=1 colspan=2>Morphine-3-β-D</td><td></td><td></td></tr><tr><td rowspan=1 colspan=2></td><td rowspan=1 colspan=2>glucuronide</td><td></td><td></td></tr><tr><td rowspan=2 colspan=2></td><td rowspan=2 colspan=2>N-Acetylprocainamide</td><td></td><td></td></tr><tr><td rowspan=1 colspan=1></td><td></td><td></td></tr><tr><td rowspan=1 colspan=4>Diphenhydramine</td><td rowspan=1 colspan=2>Nalidixic acid</td><td></td><td></td></tr><tr><td rowspan=1 colspan=4>D-Norpropoxyphene</td><td rowspan=1 colspan=2>Naloxone</td><td></td><td></td></tr><tr><td rowspan=4 colspan=4>D-PropoxypheneD,L-TyrosineDL-OctopamineDL-Propranolol</td><td rowspan=1 colspan=2>Naltrexone</td><td></td><td></td></tr><tr><td rowspan=2 colspan=2>NaproxenNiacinamide</td><td></td><td></td></tr><tr><td rowspan=1 colspan=1>Niacinamide</td><td></td><td></td></tr><tr><td rowspan=1 colspan=2>NifedipineNorcodeinNorethindroneNoscapine</td><td rowspan=1 colspan=1>Nifedipine</td><td></td><td></td></tr></table>

# Nortriptyline Interference

<table><tr><td>4-Acetamidophenol</td><td>Erythromycin</td><td>Oxycodone</td></tr><tr><td>Acetophenetidin</td><td>β-Estradiol</td><td>Oxymetazoline</td></tr><tr><td>N-</td><td>Estrone-3-sulfate</td><td>Papaverine</td></tr><tr><td>Acetylprocainamide</td><td>Ethyl-p-aminobenzoate</td><td>Penicillin-G</td></tr><tr><td>Acetylsalicylic acid Aminopyrine</td><td>Fenoprofen</td><td>Pentazocine hydrochloride Pentobarbital</td></tr><tr><td>Amobarbital</td><td>Furosemide</td><td>Perphenazine</td></tr><tr><td>Amoxicillin</td><td>Gentisic acid</td><td>Phencyclidine</td></tr><tr><td>Ampicillin</td><td>Hemoglobin</td><td>Phenelzine</td></tr><tr><td>L-ascorbic acid</td><td>Hydralazine</td><td>Phenobarbital</td></tr><tr><td>DL-Amphetamine</td><td>Hydrochlorothiazide</td><td>Phentermine</td></tr><tr><td>Hydrochlorothiazide</td><td>Hydrocodone</td><td>β-Phenylethylamine</td></tr><tr><td>Phenobarbital</td><td>Hydrocortisone</td><td>Trans-2-</td></tr><tr><td>sulfate</td><td>O-Hydroxyhippuric acid</td><td>phenylcyclopropylamine</td></tr><tr><td>Apomorphine</td><td>p-Hydroxyamphetamine</td><td>hydrochloride</td></tr><tr><td>Aspartame</td><td></td><td>L-Phenylephrine</td></tr><tr><td>Atropine</td><td>p-Hydroxy-</td><td>Phenylpropanolamine</td></tr><tr><td>Benzilic acid</td><td>methamphetamine</td><td>Prednisolone</td></tr><tr><td>Benzoic acid</td><td>3-Hydroxytyramine</td><td>Prednisone</td></tr><tr><td>Benzoylecgonine</td><td>Ibuprofen</td><td>Procaine</td></tr><tr><td>Benzphetamine</td><td>Iproniazid</td><td>DL-Propranolol</td></tr><tr><td>Bilirubin</td><td>(±) - Isoproterenol</td><td>D-Propoxyphene</td></tr><tr><td>(±)-</td><td>Isoxsuprine</td><td>D-Pseudoephedrine</td></tr><tr><td>Brompheniramine</td><td>Ketamine</td><td>Quinacrine</td></tr><tr><td>Caffeine</td><td>Ketoprofen</td><td>Quinidine</td></tr><tr><td>Cannabidiol</td><td>Labetalol</td><td>Quinine</td></tr><tr><td>Cannabinol</td><td>Loperamide</td><td>Ranitidine</td></tr><tr><td>Chloralhydrate</td><td>MDE</td><td>Salicylic acid</td></tr><tr><td>Chloramphenicol</td><td>Meperidine</td><td>Secobarbital</td></tr><tr><td>Chlorothiazide</td><td>Meprobamate</td><td>Serotonin</td></tr><tr><td>(±)</td><td>Methadone</td><td>Sulfamethazine</td></tr><tr><td>Chlorpheniramine</td><td>(L)Methamphetamine</td><td>Sulindac</td></tr><tr><td>Chlorpromazine</td><td>Methoxyphenamine</td><td>Tetracycline</td></tr><tr><td>Chloroquine</td><td>(±)-3,4-</td><td>Tetrahydrocortisone 3-(β-D-</td></tr><tr><td>Cholesterol</td><td>Methylenedioxyamphetami</td><td>glucuronide)</td></tr><tr><td>Clonidine</td><td>ne</td><td>Tetrahydrozoline</td></tr><tr><td>Cocaethylene</td><td>hydrochloride</td><td>Thiamine</td></tr><tr><td>Cocaine</td><td>Morphine-3-β-</td><td>Thioridazine</td></tr><tr><td>hydrochloride</td><td>Dglucuronide Morphine</td><td>DL-Tyrosine</td></tr><tr><td>Codeine</td><td>sulfate</td><td>Tolbutamide</td></tr><tr><td>Cortisone</td><td>Nalidixic acid</td><td>Triamterene</td></tr><tr><td>(-) Cotinine</td><td>Naloxone</td><td>Trifluoperazine</td></tr><tr><td>Creatinine</td><td>Naltrexone</td><td>Trimethoprim</td></tr><tr><td>Deoxycorticosterone</td><td>Naproxen</td><td>Tryptamine</td></tr><tr><td>Dextromethorphan</td><td>Niacinamide</td><td>DL-Tryptophan</td></tr><tr><td>Diclofenac</td><td>Nifedipine</td><td>Tyramine</td></tr><tr><td>Diflunisal</td><td>Norcodeine</td><td>Verapamil</td></tr><tr><td>Digoxin Diphenhydramine</td><td>Norethindrone D-Norpropoxyphene</td><td>Zomepirac</td></tr><tr><td>Doxylamine Ecgonine hydrochloride Ecgonine methylester Ephedrine (L) - Epinephrine</td><td>Noscapine Oxalic acid Oxazepam Oxolinic acid</td><td></td></tr></table>

# Effect of Urine Specific Gravity and Urine pH

To investigate the effect of urine specific gravity and urine $\mathrm { p H }$ , urine samples with 1.000 to 1.035 specific gravity or urine samples with $\mathrm { p H } 4$ to 9 were spiked with target drugs at $2 5 \%$ below and $2 5 \%$ above cut-off levels. These samples were tested using three batches of each device for all formats. Results were all positive for samples at and above $+ 2 5 \%$ cut-off and all negative for samples at and below $- 2 5 \%$ Cut-Off. There were no differences observed for different formats.

f. Assay cut-off:

Characterization of how the device performs analytically around the claimed cutoff concentration is described in the precision section, M.1.a. above.

2. Comparison studies:

# a. Method comparison with predicate device:

The method comparison studies for the First Sign Drug of Abuse tests (MDMA, EDDP and Nortriptyline) were performed in-house with three different laboratory assistants for each format of the device. Operators ran 80 (40 negative and 40 positive) unaltered clinical samples for each drug. The samples were blind labeled and compared to GC/MS results.

# MDMA Dip Card

<table><tr><td rowspan=1 colspan=2>Test</td><td rowspan=1 colspan=1>Drug-free</td><td rowspan=1 colspan=1>LowNegative(&lt;50%thecutoffconc)</td><td rowspan=1 colspan=1>NearCutoffNegative(Between&lt;50%below upto thecutoffconc)</td><td rowspan=1 colspan=1>NearCutoffPositive(Betweenthecutoffand50%abovecutoffconc)</td><td rowspan=1 colspan=1>HighPositive(&gt;50%abovethecutoffconc)</td></tr><tr><td rowspan=2 colspan=1>Operator A</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>26</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>Operator B</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1*</td><td rowspan=1 colspan=1>14</td><td rowspan=1 colspan=1>26</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>19</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>Operator C</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1*</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>26</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>19</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0</td></tr></table>

$\%$ agreement among positives is $9 8 . 3 \%$ $\%$ agreement among negatives is $9 8 . 3 \%$ \* Samples contained MDMA at 474 and $4 6 8 ~ \mathrm { { n g / m L } }$ † Samples contained MDMA at 544 and $5 6 1 ~ \mathrm { { n g / m L } }$

# MDMA Cup

<table><tr><td rowspan=1 colspan=2>Test</td><td rowspan=1 colspan=1>Drug-free</td><td rowspan=1 colspan=1>LowNegative(&lt;50%thecutoffconc)</td><td rowspan=1 colspan=1>NearCutoffNegative(Between&lt;50%below upto thecutoffconc)</td><td rowspan=1 colspan=1>NearCutoffPositive(Betweenthecutoffand50%abovecutoffconc)</td><td rowspan=1 colspan=1>HighPositive(&gt;50%abovethecutoffconc)</td></tr><tr><td rowspan=2 colspan=1>Operator A</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1*</td><td rowspan=1 colspan=1>14</td><td rowspan=1 colspan=1>26</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>Operator B</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>26</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>1↑</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>Operator C</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1*</td><td rowspan=1 colspan=1>14</td><td rowspan=1 colspan=1>26</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>19</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td></tr></table>

$\%$ agreement among positives is $9 9 . 2 \%$ $\%$ agreement among negatives is $9 8 . 3 \%$ \* Samples contained MDMA at 470 and $4 7 7 \mathrm { n g / m L }$ † Samples contained MDMA at $5 1 7 \mathrm { n g / m L }$

# EDDP Dip Card

<table><tr><td rowspan=1 colspan=2>Test</td><td rowspan=1 colspan=1>Drug-free</td><td rowspan=1 colspan=1>LowNegative(&lt;50%thecutoffconc</td><td rowspan=1 colspan=1>NearCutoffNegative(Between&lt;50%below upto thecutoffconc)</td><td rowspan=1 colspan=1>NearCutoffPositive(Betweenthecutoffand50%abovecutoffconc)</td><td rowspan=1 colspan=1>HighPositive(&gt;50%above thecutoffconc</td></tr><tr><td rowspan=2 colspan=1>Operator A</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1*</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>26</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>19</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>Operator B</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1*</td><td rowspan=1 colspan=1>14</td><td rowspan=1 colspan=1>26</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>19</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>Operator C</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1*</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>26</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>19</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0</td></tr></table>

$\%$ agreement among positives is $9 8 . 3 \%$ $\%$ agreement among negatives is $9 7 . 5 \%$ \* Samples contained EDDP at 260, 269, and $2 7 6 ~ \mathrm { { n g / m L } }$ $\dagger$ Samples contained EDDP at 340 and $3 4 4 ~ \mathrm { { n g / m L } }$

# EDDP Cup

<table><tr><td rowspan=2 colspan=2>Test</td><td rowspan=2 colspan=1>Drug-free</td><td rowspan=1 colspan=1>Low</td><td rowspan=2 colspan=1>NearCutoffNegative(Between&lt;50%below upto thecutoffconc)</td><td rowspan=2 colspan=1>NearCutoffPositive(Betweenthecutoffand50%abovecutoffconc)</td><td rowspan=2 colspan=1>HighPositive(&gt;50%abovethecutoffconc)</td></tr><tr><td rowspan=1 colspan=1>Negative(&lt;50%thecutoffconc)</td></tr><tr><td rowspan=2 colspan=1>Operator A</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1*</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>26</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>19</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>Operator B</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>26</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0</td></tr></table>

<table><tr><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1*</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>26</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>19</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0</td></tr></table>

$\%$ agreement among positives is $9 7 . 5 \%$ $\%$ agreement among negatives is $9 8 . 3 \%$ \* Samples contained EDDP at 266 and $2 6 9 \mathrm { n g / m L }$ $\dagger$ Samples contained EDDP at 340, 342, and $3 4 4 ~ \mathrm { { n g / m L } }$

# Nortriptyline Dip Card

<table><tr><td rowspan=1 colspan=2>Test</td><td rowspan=1 colspan=1>Drug-free</td><td rowspan=1 colspan=1>LowNegative(&lt;50%thecutoffconc)</td><td rowspan=1 colspan=1>NearCutoffNegative(Between&lt;50%below upto thecutoffconc)</td><td rowspan=1 colspan=1>NearCutoffPositive(Betweenthe cutoffand50%abovecutoffconc)</td><td rowspan=1 colspan=1>HighPositive(&gt;50%abovethecutoffconc)</td></tr><tr><td rowspan=2 colspan=1>Operator A</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1*</td><td rowspan=1 colspan=1>14</td><td rowspan=1 colspan=1>26</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>19</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>Operator B</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1*</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>26</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>19</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>Operator C</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1*</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>26</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>19</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0</td></tr></table>

$\%$ agreement among positives is $9 8 . 3 \%$ $\%$ agreement among negatives is $9 7 . 5 \%$ \* Samples contained Nortriptyline at 851, 863, and $8 7 9 ~ \mathrm { { n g / m L } }$ $^ \dagger$ Samples contained Nortriptyline at 1069 and $1 1 2 5 ~ \mathrm { n g / m L }$

# Nortriptyline Cup

<table><tr><td colspan="2" rowspan="1">Test</td><td colspan="1" rowspan="1">Drug-free</td><td colspan="1" rowspan="1">LowNegative(&lt;50%thecutoffconc)</td><td colspan="1" rowspan="1">NearCutoffNegative(Between&lt;50%below upto thecutoffconc)</td><td colspan="1" rowspan="1">NearCutoffPositive(Betweenthecutoffand50%abovecutoffconc)</td><td colspan="1" rowspan="1">HighPositive(&gt;50%abovethecutoffconc)</td></tr><tr><td colspan="1" rowspan="2">Operator A</td><td colspan="1" rowspan="1">Positive</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">1*</td><td colspan="1" rowspan="1">13</td><td colspan="1" rowspan="1">26</td></tr><tr><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">19</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">0</td></tr><tr><td colspan="1" rowspan="2">Operator B</td><td colspan="1" rowspan="1">Positive</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">1*</td><td colspan="1" rowspan="1">14</td><td colspan="1" rowspan="1">26</td></tr><tr><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">19</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td></tr><tr><td colspan="1" rowspan="2">Operator C</td><td colspan="1" rowspan="1">Positive</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">13</td><td colspan="1" rowspan="1">26</td></tr><tr><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">0</td></tr></table>

$\%$ agreement among positives is $9 8 . 3 \%$ $\%$ agreement among negatives is $9 8 . 3 \%$ \* Samples contained Nortriptyline at 851 and $8 7 0 ~ \mathrm { { n g / m L } }$ $^ \dagger$ Samples contained Nortriptyline at 1084 and $1 1 3 5 \mathrm { n g / m L }$

b. Matrix comparison: N/A

3. Clinical studies: a. Clinical Sensitivity: N/A b. Clinical specificity: N/A

c. Other clinical supportive data (when a. and b. are not applicable):

# Lay User Study

A lay user study was performed at three intended user sites with 280 lay persons testing the MDMA devices, 280 lay persons testing the EDDP devices and 280 lay persons testing the Nortriptyline devices. A total of 140 females and 140 males tested the MDMA samples, 141 females and 139 males tested EDDP samples, and 141 females and 139 males tested the Nortriptyline samples. They had diverse educational and professional backgrounds and ranged in age from 21 to $> 5 0$ years. Urine samples were prepared at the following concentrations; negative, $+ / - 7 5 \%$ , $+ / - 5 0 \%$ , $+ / - 2 5 \%$ of the cutoff by spiking drugs into drug free-pooled urine specimens. The concentrations of the samples were confirmed by GC/MS. Each sample was aliquoted into individual containers and blind-labeled. Each participant was provided with the package insert, 1 blind labeled sample and a device.

Lay-users were also given surveys on the ease of understanding the package insert instructions. All lay users indicated that the device instructions can be easily followed. A Flesch-Kincaid reading analysis was performed on each package insert and the scores revealed a reading Grade Level of 7.

# MDMA Dip Card

<table><tr><td rowspan=2 colspan=1>% of Cutoff</td><td rowspan=2 colspan=1>Numberofsamples</td><td rowspan=2 colspan=1>MDMAConcentrationby GC/MS(ng/mL)</td><td rowspan=1 colspan=2>Lay person results</td><td rowspan=2 colspan=1>Thepercentageof correctresults(%)</td></tr><tr><td rowspan=1 colspan=1>No. ofPositive</td><td rowspan=1 colspan=1>No. ofNegative</td></tr><tr><td rowspan=1 colspan=1>-100%Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>-75%Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>115</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>-50% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>237</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>-25% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>358</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>+25% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>598</td><td rowspan=1 colspan=1>19</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>95</td></tr><tr><td rowspan=1 colspan=1>+50% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>755</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>+75% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>912</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100</td></tr></table>

# MDMA Cup

<table><tr><td rowspan=2 colspan=1>% of Cutoff</td><td rowspan=2 colspan=1>Numberofsamples</td><td rowspan=2 colspan=1>MDMAConcentrationby GC/MS(ng/mL)</td><td rowspan=1 colspan=2>Lay person results</td><td rowspan=2 colspan=1>Thepercentageof correctresults(%)</td></tr><tr><td rowspan=1 colspan=1>No. ofPositive</td><td rowspan=1 colspan=1>No. ofNegative</td></tr><tr><td rowspan=1 colspan=1>-100%Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>-75%Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>115</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>-50% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>237</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>-25% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>358</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>19</td><td rowspan=1 colspan=1>95</td></tr><tr><td rowspan=1 colspan=1>+25% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>598</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>+50% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>755</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>+75% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>912</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100</td></tr></table>

# EDDP Dip Card

<table><tr><td rowspan=2 colspan=1>% of Cutoff</td><td rowspan=2 colspan=1>Numberofsamples</td><td rowspan=2 colspan=1>EDDPConcentration byGC/MS (ng/mL)</td><td rowspan=1 colspan=2>Lay person results</td><td rowspan=2 colspan=1>Thepercentageof correctresults(%)</td></tr><tr><td rowspan=1 colspan=1>No. ofPositive</td><td rowspan=1 colspan=1>No. ofNegative</td></tr><tr><td rowspan=1 colspan=1>-100%Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>-75%Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>81</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>-50%Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>157</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>-25%Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>235</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>18</td><td rowspan=1 colspan=1>90</td></tr><tr><td rowspan=1 colspan=1>+25%Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>410</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>+50%Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>485</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>+75%Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>566</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100</td></tr></table>

# EDDP Cup

<table><tr><td rowspan=2 colspan=1>% of Cutoff</td><td rowspan=2 colspan=1>Numberofsamples</td><td rowspan=2 colspan=1>EDDPConcentrationby GC/MS(ng/mL)</td><td rowspan=1 colspan=2>Lay person results</td><td rowspan=2 colspan=1>The percentage ofcorrect results (%)</td></tr><tr><td rowspan=1 colspan=1>No. ofPositive</td><td rowspan=1 colspan=1>No. ofNegative</td></tr><tr><td rowspan=1 colspan=1>-100%Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>-75%Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>81</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>-50%Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>157</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>-25%Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>235</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>19</td><td rowspan=1 colspan=1>95</td></tr><tr><td rowspan=1 colspan=1>+25%Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>410</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>+50%Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>485</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>+75% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>566</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100</td></tr></table>

Nortriptyline Dip Card   

<table><tr><td rowspan=2 colspan=1>% of Cutoff</td><td rowspan=2 colspan=1>Numberofsamples</td><td rowspan=2 colspan=1>NortriptylineConcentrationby GC/MS(ng/mL)</td><td rowspan=1 colspan=2>Lay person results</td><td rowspan=2 colspan=1>The percentage ofcorrect results (%)</td></tr><tr><td rowspan=1 colspan=1>No. ofPositive</td><td rowspan=1 colspan=1>No. ofNegative</td></tr><tr><td rowspan=1 colspan=1>-100%Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>-75%Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>261</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>-50%Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>495</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>-25%Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>720</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>19</td><td rowspan=1 colspan=1>95</td></tr><tr><td rowspan=1 colspan=1>+25%Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>1180</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>+50%Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>1485</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>+75%Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>1687</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100</td></tr></table>

Nortriptyline Cup   

<table><tr><td rowspan=2 colspan=1>% of Cutoff</td><td rowspan=2 colspan=1>Numberofsamples</td><td rowspan=2 colspan=1>NortriptylineConcentration by GC/MS(ng/mL)</td><td rowspan=1 colspan=2>Lay person results</td><td rowspan=2 colspan=1>Thepercentageof correctresults(%)</td></tr><tr><td rowspan=1 colspan=1>No. ofPositive</td><td rowspan=1 colspan=1>No. ofNegative</td></tr><tr><td rowspan=1 colspan=1>-100%Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>-75%Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>261</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>-50%Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>495</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>-25%Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>720</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>19</td><td rowspan=1 colspan=1>95</td></tr><tr><td rowspan=1 colspan=1>+25%Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>1180</td><td rowspan=1 colspan=1>19</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>95</td></tr><tr><td rowspan=1 colspan=1>+50%Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>1485</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>+75% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>1687</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100</td></tr></table>

4. Clinical cut-off: N/A

5. Expected values/Reference range: N/A

# N. Proposed Labeling:

The labeling is sufficient and it satisfies the requirements of 21 CFR Part 809.10.

# O. Conclusion:

The submitted information in this premarket notification is complete and supports a substantial equivalence decision.